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Abstract. The kinetics of estrogen-induced accumulation of riboflavin-carrier protein in the 
plasma was investigated in immature male rats using a specific and sensitive homologous radio- 
immunoassay procedure developed for this purpose. Following a single injection of the 
steroid hormone, plasma riboflavin-carrier protein levels increased markedly after an initial lag 
period of approximately 24 h, reaching peak levels around 96 h and declining thereafter. A 1.5 
fold amplification of the inductive response was evident on secondary stimulation with the 
hormone. The magnitude of the response was dependent on hormonal dose, whereas the 
initial lag phase and the time of peak riboflavin-carrier protein induction were unaltered within 
the range of the steroid doses (0.1-10 mg/ kg body wt.) tested. Simultaneous administration of 
progesterone did not affect either the kinetics or the maximum level of the protein induced. 
The hormonal specificity of this induction was further adduced by the effect of administration 
of antiestrogens viz., En and Zu chlomiphene citrates, which effectively curtailed hormonal 
induction of the protein. That the induction involved de novo-protein synthesis was evident 
from the complete inhibition obtained upon administration of cycloheximide. Passive 
immunoneutralization of endogenous riboflavin-carrier protein with antiserum to the homolo- 
gous protein terminated pregnancy in rats confirming the earlier results with antiserum to 
chicken riboflavin-carrier protein.
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Introduction 
 
In the chicken (and presumably in other oviparous species also), adequate 
deposition in the egg of water-soluble vitamins like riboflavin (Rhodes et al., 1959; 
Murty and Adiga, 1977), thiamin (Muniyappa and Adiga, 1981), biotin(Eakin et al., 
1940; White et al., 1976; Murthy and Adiga, 1980) etc. for utilisation by and proper 
development of the prospective embryo, is accomplished by the obligatory partici- 
pation of the high-affinity carrier proteins specific to each of these vitamins. 
Earlier, we showed that all these egg proteins are inducible specifically by estrogen 
(Murty and Adiga, 1978; Muniyappa and Adiga, 1980a; Ramana Murty and 
Adiga, unpublished) either in the adult male or immature animals of either sex. 
 
 
Abbreviations used: RCP,riboflavin-carrier protein; TCP, thiamine carrier protein; BCP, biotin carrier 
protein. 
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Notwithstanding the marked difference in the patterns of embryonic development 
in the oviparous species vis-a-vis the mammals, we could demonstrate recently that 
in the pregnant rat also, a similar gestation-specific, high-affinity carrier-protein 
with immunological cross-reactivity to the purified chicken riboflavin-carrier 
protein (RCP), mediates the transplacental transport and foetal accumulation of 
riboflavin (Muniyappa and Adiga, 1980b; Murty and Adiga, 1981). The rodent 
RCP was purified to homogeneity (Muniyappa and Adiga, 1980c) and its functional 
importance in foetal development demonstrated. For example, it was shown that 
immunoneutralisation of this maternal protein in the pregnant rat by specific 
antiserum to chicken RCP precipitates acute flavin deficiency in the developing 
conceptus with a resultant marked foetal wastage followed by termination of 
pregnancy (Murty and Adiga, 1981). During attempts to understand the 
endocrine basis of the elaboration of this protein in the rat, we found using hetero- 
logous radioimmunoassay, that RCP levels in the cycling female rats were 
modulated in synchrony with the changing estrogen levels and that the steroid 
hormone could induce this protein de novo in ovarectomised female rats 
(Muniyappa and Adiga, 1980b). In the present paper, we report a homologous 
radioimmunoassay for estimating RCP and provide information on the kinetics of 
its induction by estradiol-17β in the immature male rat in response to both primary 
and secondary stimulation as well as the influence of specific hormonal antagonists 
and other factors thereon. Availability for the first time of the potent antiserum to 
the rodent protein prompted a reinvestigation of the effect of passive immuno- 
neutralisation of RCP on the course of pregnancy in this mammal.
 
 
Materials and methods
 
Thirty day old male rats (Wistar) of our Institute Colony were fed a pelleted diet 
(Hindustan Lever Products, Bombay) and water ad libitum and exposed to a 
14h:10h light-dark schedule. The purification of RCP from pregnant rat serum 
was accomplished according to the published procedure (Muniyappa and Adiga, 
1980c). The antiserum against the purified rat RCP was raised in rabbits by 
subcutaneous injections of the protein (100 µg) emulsified with Freund’s complete 
adjuvant, once in a week, for 3 weeks followed by a booster dose of the protein (200 
µg) in saline. A week after the booster, blood was collected through the ear vein, 
and the serum prepared and kept frozen at –20°C. Na 125I for iodination of the 
protein, was purchased from the Radiochemical Centre, Amersham, Bucks, U.K. 
The sources of other chemicals and reagents were the same as described earlier 
(Muniyappa & Adiga, 1980). The female rats used in passive immunoneutralisa- 
tion experiments were 80-100 day old, and day 1 of pregnancy was the day on which 
the sperms were detected in the vaginal smear. Antiserum (0.5 ml) was injected 
intraperitoneally on the 11th day of pregnancy, after inactivating the complement 
in the serum by warming in a water bath at 52°C for 5 minutes. Laprotomy was 
performed on day 8 to count the number of implantation sites on their uterine 
horns. Hormones and antiestrogens in propane-l,2-diol were injected intra- 
muscularly, whereas cycloheximide in 0.15M NaCl was administered intraperi- 
tonially. 
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Homologous radioimmunoassay for riboflavin carrier protein 
 
The iodination of RCP was carried out at 4°C by the procedure of Greenwood et 
al. (1963). Briefly, 2.5 µg of the protein in 25 µl of 100 mM-sodium phosphate 
buffer, pH 7.2 was treated for 45 s with 0.25 mCi of carrier-free Na 125I in the 
presence of 25 µl of chloramine Τ (1 mg/ml) and the iodination was terminated with 
the addition of 25 µl of sodium metabisulphite (10 mg/ml). The iodinated protein 
was separated from the free iodine using a column (0.6 cm × 20 cm) of Sephadex G- 
75 pre-equlibrated with 0.15 Μ NaCl in 10 mM-sodium phosphate buffer, pH 7.5 
containing 0.5% (w/v) gelatin. The presence of gelatin ensured the complete 
recovery of the protein from the column. Small portions (25 µl) from each fraction 
(1 ml) were counted for radioactivity in a gamma counter (Packard Autogamma, 
Model 2002). The iodinated protein was stored frozen in small batches in the 
presence of 2% (w/v) bovine serum albumin until use.
 
Immunoassay procedure
 
An antiserum dilution capable of binding 25-40% of the labelled protein was 
selected. The assay was performed in glass tubes (Moudgal and Madhwaraj, 1974) 
at 37°C in a water bath. Rat RCP (1-200 ng) standards duplicates, and 0.05-0.1 ml 
portions of unknown samples were incubated with antiserum (0.1 ml) along with 
non-immunised rabbit serum as controls, for 10-12 h. Labelled protein (Ca 50,000 
cpm) was added to all the tubes and the incubation was continued for another 12 h 
and the antigen-antibody complex was precipitated by the double-antibody 
method (Murthy and Adiga, 1978) in the presence of a carrier viz. 0.1 ml of 1:50 
diluted normal rabbit serum. The precipitate was sedimented by centrifugation at 
2000 g for 20 min and the radio activity measured. The amounts of RCP in the 
unknown samples were calculated by extrapolation from the standard curve 
(figure 1) that was constructed using various known amounts of unlabelled protein 
 
 
 
Figure 1. Standard curve for the radioimmunoassay for rat riboflavin carrier protein. The 
dilution of the antiserum used was 1:5000. For other details see the text.
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to inhibit the binding of the labelled protein. The total bound radioactivity in the 
protein refers to the amount of specifically-bound radioactivity in the absence of 
unlabelled protein. The non-specific binding (to non-immunised rabbit serum) was
5-10% of the total input radioactivity and this was always subtracted.
 
Inter assay and intra assay variations: 
 
Aliquot from a single pooled serum sample was analysed 4-8 times for intra-assay 
and 4 times for inter-assay variation and the data were analysed statistically 
(Mulholland & Jones, 1968). Coefficients of intra and inter-assay variations were 
2-6% and 3-5% respectively and the assay method had a sensitivity of 3.5 ng/tube. 
The homologous radio-immunoassay reported here had approximately 2 fold 
higher sensitivity compared to the earlier heterologous radioimmunoassay 
(Muniyappa and Adiga, 1980b).
 
Results 
 
The preliminary evidence (Muniyappa & Adiga, 1980b) that the rat RCP, like its 
avian counterpart, is inducible in the mammalian liver by estrogen was based on 
the measurement of circulating levels of this protein in the steroid-treated 
overectomized female rats using a heterologous radioimmunoassay which reflected 
only the relative concentrations of the protein in the plasma. To assess the 
absolute content of this vitamin-carrier following estrogenization, a sensitive 
radioimmunoassay was evolved after the purified rat RCP and its specific 
antiserum became available. Having accomplished this, a detailed investigation of 
the time course of accumulation of this protein in the plasma after hormonal dosing 
was undertaken. The time-course of accumulation and disappearance of RCP 
during both primary and secondary stimulations with the steroid (10 mg/kg body 
weight) in 30-day old male rats is depicted in figure 2. The plasma levels of the 
vitamin-carrier measured prior to hormone treatments represented the respective 
base-line values which were low (30-50 ng/ml). The increments, if any, in these
 
 
 
Figure 2. Time course of accumulation of riboflavin carrier protein in the plasma after 
sequential injections (EI, EII) of oestradioi-17β in propane-l,2-diol (10 mg/kg body wt). The 
values represent means and vertical bars represent S.D. (n=5).
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levels were not significant for nearly 24h after estrogen treatment. Beyond this 
initial lag period, the RCP concentrations rose gradually with time reaching a peak 
value of approximately 750 ng/ml at around 96h in conformity with the earlier data 
(Muniyappa and Adiga, 1980b). This was followed by a steady decline and by day 
10, the levels returned to the preinjection base-line values.
 
Sixteen days after withdrawal of the steroid, when the same animals were again 
challenged with a second dose of estradiol-17β (10 mg/kg body weight) the 
circulating concentration of RCP exhibited a similar kinetic pattern except that the 
response was considerably magnified; in fact, a typical ‘memory effect’ observed 
earlier during the elaboration of vitellogenin (Gruber et al., 1976), RCP (Murthy 
and Adiga, 1978), thiamine-carrier protein (Muniyappa and Adiga, 1980a) and 
biotin-carrier protein (Ramana Murty and Adiga, unpublished observations) in 
estrogen treated chicken liver was clearly evident. During this secondary 
stimulation, the amplification of the estrogenic response in terms of RCP induction 
was more than 1.5 fold. Though the peak plasma concentration of RCP was 
enhanced by a similar order of magnitude during the secondary stimulation, the 
time-course of accumulation and disappearance of the protein in circulation 
exhibited qualitatively the same pattern following the two hormonal stimuli. 
However, a comparison of the slopes of the respective ascending phases of RCP 
accumulation clearly shows that the rate of induction, especially during early 
phases, is significantly enhanced after secondary stimulation vis-a-vis primary 
stimulation. 
 
Hormonal dose-dependency and time-course of RCP elaboration during primary 
stimulation 
 
Varying doses of estradiol-17β were administered to young male rats during the 
primary stimulation to quantify the corresponding changes in the rates and the 
magnitudes of plasma accumulation and disappearance of RCP. It is evident from 
figure 3 that as low a dose as 100 µg/kg body weight (i.e., less than 10 µg/animal) of 
the steroid could induce a measurable response which progressively increased with 
the hormonal dose. However, the time taken to reach the maximal protein levels
following hormonal dosing remained the same within the range of the steroid
dosage tested (0.1-10 mg/kg body weight). But the rates of accumulation and
disappearance from circulation as well as the peak levels reached exhibited a dose- 
dependent phenomenon.
 
Influence of cycloheximide
 
One possibility that the rapid accumulation of RCP in the plasma after hormone 
administration, merely reflects an interference with the altered metabolic clearance
rate and not necessarily de novo synthesis was tested by administration of cyclo- 
heximide, a powerful inhibitor of protein synthesis. When this (drug was injected 
intraperitoneally (0.8 mg/kg body weight) 30 minutes prior to steroid administra- 
tion a drastic decrease in RCP levels was observed at 72h, i.e., at a time when many 
fold increase in RCP concentration was otherwise encountered (table 1).
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Figure 3. Hormonal dose-dependent reponse of the plasma riboflavin carrier protein during 
primary stimulation. Time course of plasma riboflavin carrier protein accumulation with 
increasing concentrations of oestradiol-17β (mg/kg body wt.):■, 0.1; 0, 0.5;●,1; ∆, 5.0;▲, 
10.0. The values represent means and vertical bars represent S.D. (n=5). 
 
 
 
Table 1. Effect of administration of cycloheximide on estradiol-induced riboflavin carrier 
protein accumulation in the plasma.
 
 
Cycloheximide (0.8 mg/kg body wt ) was administered intraperitoneally 30 min prior to 
injection of estradiol 17β and plasma riboflavin-carrier protein levels estimated at 72 h after 
estrogenisation. Data expressed as means ±S.D. (n=4).
 
 
Effect of progesterone and antiestrogens
 
Earlier observations with the chicken oviduct system that there exists an 
antagonism between estrogen and progesterone in terms of ovalbumin induction 
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during primary stimulation (Palmiter and Wren, 1971) could not be demonstrated 
with the estrogenized chicken liver system elaborating RCP, thiamine- and biotin-
carrier proteins (Murty and Adiga, 1978; Muniyappa and Adiga, 1980a, Ramana 
Murty and Adiga, unpublished results). It was therefore of interest to investigate
whether RCP induction in rat by estradiol is modulated by progesterone 
administered either alone or in combination with estradiol. From the data of 
figure 4, it is unequivocally clear that progesterone did not exhibit any discernible 
influence on the kinetics of estrogen-induced RCP production in the rodent with 
regard to either the initial lag phase or the subsequent rates of RCP accumulation 
and decay in the circulation or the peak levels of the protein reached at around 96 h 
after estradiol treatment.
 
Figure 4. Time course of appearance of riboflavin carrier protein in the plasma on treatment 
with estradiol-17β (10 mg/kg body wt) + progesterone (10 mg/kg body wt) (●), and 
progesterone (10 mg/kg body wt) alone (O).
 
The values represent means and the vertical bars represent S.D. (n=5).
 
In order to further substantiate this hormonal specificity of RCP induction in the 
rat, the potent antiestrogens viz., En- and Zu-clomiphene citrates were administered 
to the animals 30 min prior to the estrogen treatment and the plasma RCP levels 
were quantified at 72 h. From the results presented in table 2, it is clear that both 
the antiestrogens have effectively curtailed the estrogenic response besides being 
ineffective by themselves to elicit even weak estrogen-like activity with regard to 
RCP induction. 
 
Passive immunoneutralization with homologous antiserum and effect on pregnancy 
progression in the female rats –
 
The previous observation (Muniyappa and Adiga, 1980b) that RCP is vitally 
involved in transplacental flavin transport to supply vitamin to the growing 
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Table 2. Influence of antiestrogens on the estradiol-17β stimulated plasma riboflavin carrier 
protein content.
 
En- and Zu-clomiphene citrates (10 mg/kg body wt) were administered 30 min prior to 
estradiol-17β administration and plasma riboflavin carrier proteins were estimated at 72 h after 
estrogenisation. Data are expressed as means ±S.D. (n=4).
 
foetuses, was based on the observation that passive immunoneutralisation with the 
antiserum to the chicken RCP led to foetal wastage followed by termination of 
pregnancy. With the availability of a potent antiserum to the homologous protein, 
it was desirable to study the influence of neutralization of endogenous RCP by this 
antiserum on the progression of pregnancy in the rodent. The data of table 3 
 
Table 3. The influence of the specific antiserum to the rat riboflavin carrier protein on 
pregnant rats.
 
 
The pregnant rats (11 day) were treated with either the non-immune rabbit serum (NRS) (0.5 
ml), or ovomucoid antiserum or antiserurm to the purified rat riboflavin carrier protein raised in 
rabbits (0.5 ml/rat). nT=total number of implantation sites; T=average implantation sites/ 
animal determined at laprotomy. The sera were incubated at 52°C for 5 min to inactivate the 
complement and were administered intraperitoneally. A/S=antiserum.
 
provide unequivocal evidence that intraperitoneal administration to pregnant rats 
of adequate quantities of the antiserum to the homologous RCP on day 11 of 
gestation proved deleterious and resulted in 100% termination of pregnancy within 
 
Hormonal induction of riboflavin-carrier protein in rat 235 
 
24-28h after antiserum administration. It was also found that this phenomenon 
was preceded by slight vaginal bleeding in these animals. In contrast, pregnant 
animals treated with either non-immunised rabbit serum or with antiserum to a 
highly immunogenic protein viz. ovomucoid were unaffected in terms of suppression 
of pregnancy. 
 
Discussion 
 
Consistent with our earlier observations with ovarectomised female rats (Muniyappa 
and Adiga, 1980b), the data presented above amply substantiate that a single 
injection of estradiol-17β induces RCP in a dose-dependent manner in immature 
male rats as well. A comparison of these kinetic data with those obtained earlier 
with chicken (Murthy and Adiga, 1978) reveal several interesting similarities in the 
induction of RCP in the two species of animals. Quantitatively, these extend from 
initial lag phase during which no significant protein accumulates in the plasma, 
through the patterns of rapid rise and decay in plasma concentrations during 
primary induction, to significant amplification of the inductive response during 
secondary stimulation with the steroid. Quantitatively, however, the rodent liver 
responding to the hormone in terms of RCP induction seems kinetically more 
sluggish as judged from the relatively protracted initial lag phase (of nearly 24 h 
compared to 4-5 h in the chicken,(Murthy and Adiga, 1978), an extended duration 
of both ascending and descending phases and relatively lower magnitude of 
amplification during secondary stimulation. Nonetheless, overall similarity in the 
pattern of RCP induction in the two species is clearly evident. That the underlying 
mechanism may also be analogous is supported by the finding, that as in the chicken 
liver (Lazier & Haggarty, 1979), specific, high-affinity cytoplasmic estrogen 
receptors capable of rapid nuclear translocation and functional interaction with 
chromatin acceptor sites exist in hepatocytes of both the male and female rats (Atew 
et al., 1978) and that hormone administration brings about marked changes in the 
composition and function of the mammalian liver (Seal and Doe, 1969).
 
The characteristic ‘memory effect’ with attendant amplification of the inductive 
response (figure 2) seen during secondary stimulation with the hormonal steroid 
has also been observed earlier with the estrogenised liver synthesizing RCP 
(Murthy and Adiga, 1978), TCP (Muniyappa and Adiga, 1980a) biotin binding 
protein (Ramana Murty and Adiga, unpublished observation) and in chicken 
(Gruber et al., 1976) and amphibian (Tata, 1976) liver systems elaborating 
vitellogenin. Though the intricacies of exact molecular mechanism involved need 
further elucidation, more pronounced transcription presumably due to permanent 
changes in chromatin (Jost et al., 1978) and rapid translation due to stabilization of 
mRNAs during this period have been definitely established as dominant parameters 
responsible for more efficient induction of these proteins. Furthermore, recent 
investigations with X. laevis (Hayward et al., 1981) have shown that enhanced 
synthesis as well as marked redistribution of available estrogen receptors between 
nuclear and cytoplasmic components of the hepatocytes with resultant availability 
of relatively more cytoplasmic receptors for rapid nuclear translocation of the 
hormone during secondary stimulation may also be an important contributory 
factor in this regard. Whatever the underlying mechanism, it is clear from the
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results of figure 2 that the amplification of estrogen-induced specific gene 
expression during secondary stimulation is not confined to oviparous species, but 
extends to mammals also. The only other instance of this kind demonstrated 
hitherto in mammals is related to enhanced production of prolactin mRNA (but 
not its translation product) in the pituitary of male rats repeatedly treated with 
estrogen (Seo et al., 1979). However, it is pertinent to point out that prolactin, 
unlike RCP, is a normal constituent and secretory product of the pituitary tissue 
and that the steroid only enhances the expression of its gene and does not induce its 
synthesis de novo. 
 
It is now well documented that estrogen administration brings about the 
modulation of synthesis of several plasma proteins in the mammalian liver (Seal
and Doe, 1969); the plasma renin substrate is notable among these in that its levels 
can be enhanced by the steroid hormone in a dose-dependent manner in the adult 
rat though not in prepubertal rats, which have limited population of hepatic 
estradiol receptors available at this stage (Dickson and Eisenfeld, 1979). The 
reasons for age-dependant difference in inducibility between plasma rennin 
substrate and RCP are not clear at present. It may be related to the fact that 
different threshold concentrations of estrogen-receptor complex may be needed at 
nuclear chromatin acceptor sites for the induction of different proteins (Palmiter, 
et al., 1981). Based on this premise, it is reasonable to surmise that relatively lower 
levels of estrogen-receptors available in prepubertal rat liver are sufficient to 
induce RCP, but not plasma renin substrate. The proof of this hypothesis however 
awaits further study.
 
Another intriguing facet of analogy between the rat and the chicken systems with 
regard to RCP induction is the hormonal specificity as exemplified by complete 
lack of response to progesterone, either alone or in combination with estrogen 
(figure 4). Further support for this specificity stems from the data in table 2 
regarding complete blockade of RCP induction by anti-estrogens. Again as 
opposed to the findings with rat uterus (Mohla and Prasad, 1969) these antihormones 
failed to exhibit any descernible estrogen-like activity by themselves in terms of 
RCP induction in the rodent liver.
 
From the foregoing, it is clear that despite marked differences between the rat 
and the oviparous species in the patterns of embryonic development, the carrier- 
protein-mediated vitamin delivery mechanism is conserved during evolution of 
species. The similarity is not only in some structural and functional features of the 
carrier protein but also with respect to the pattern of hormonal inducibility in the 
liver. Since the data of table 3 clearly reinforce the earlier postulation that RCP is
vitally concerned with embryonic development in both the species (Muniyappa 
and Adiga, 1980b; Murty and Adiga, 1981), it is clear that estrogen-induced specific 
protein synthesis in mammalian liver is not merely an evolutionary vestige and that 
in the female mammal some of these proteins may have an important function
during pregnancy as nutrient carriers for embryonic development. Viewed from 
this angle, it would appear that the mammalian liver, like its avian counterpart
(Gruber et al., 1976) can also be considered as an accessory sex organ.
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